Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-83883-w, published online 25 February 2021
The original version of this Article contained an error in Figure 2B, where an incorrect panel was mistakenly included as panel (f). This panel has been removed, and cannot be replaced due to antibody issues affecting reproducibility. The original Figure 2 and accompanying legend appear below.
As a result, in the legend of Figure 2,
“(e) Immunofluorescence staining for nephrin in FSGS and CTRL serum injected zebrafish at 120 hpf. Zebrafish larvae were injected with serum from a healthy control and from a patient with FSGS recurrence in the kidney transplant at 48 hpf. Scale bar = 100 μm. (f) Electron microscopy picture of the glomerular filtration barrier of 5 day old zebrafish larvae that were injected with either serum of the patient from the time of FSGS recurrence or with CTRL serum at 48 hpf.”
now reads:
“(e) Electron microscopy picture of the glomerular filtration barrier of 5 day old zebrafish larvae that were injected with either serum of the patient from the time of FSGS recurrence or with CTRL serum at 48 hpf.”
Additionally, in the Results section under the subheading ‘Ex vivo tests to detect morphological changes in podocytes caused by FSGS serum’,
“We performed immunofluorescent staining and transmission electron microscopy of the zebrafish pronephros of fish that were injected with the serum of the FSGS patient from the time of disease recurrence and could show reduced nephrin expression (Fig. 2Be) and podocyte effacement compared to CTRL serum injected zebrafish (Fig. 2Bf).”
now reads:
“We performed transmission electron microscopy of the zebrafish pronephros of fish that were injected with the serum of the FSGS patient from the time of disease recurrence and could show podocyte effacement compared to CTRL serum injected zebrafish (Fig. 2Be).”
Furthermore, in the Discussion section,
“We injected serum of patient with recurrent FSGS in the cardinal vein of the zebrafish and detected a significant loss of plasma proteins, reduced nephrin and partial podocyte effacement 3 days later.”
now reads:
“We injected serum of patient with recurrent FSGS in the cardinal vein of the zebrafish and detected a significant loss of plasma proteins and partial podocyte effacement 3 days later.”
Finally, in the Methods section, the subsection entitled ‘Immunofluorescence staining of zebrafish larvae’ has been removed.
“For paraffin tissue sections, zebrafish larvae were fixed in 2% PFA for 1 day, dehydrated in ascending concentrations of ethanol in PBS (25%, 50%, 70%, and 100%) and transferred in xylene (100%) for 5 min before embedding in paraffin (60 °C) overnight. With a rotational microtome (Leica SM 2000 R) sections of 5 μm were cut, incubated in ethanol (100%, 70%, 50%, and 25%). For cryosections larvae were fixed in 2% PFA for 2 h followed by an overnight incubation in 30% saccharose at 4 °C. After embedding the larvae in Tissue-Tek (Sakura, Staufen, Germany), sectsions (20 μm, 60 μm) were cut using a Leica CM 1950 microtome and stained with antibodies. The following primary antibodies were used: anti-zebrafish nephrin (zNephrin, Innovagen, Sweden) 1:8000, Alexa Fluor 488 goat anti-rabbit (life technology) 1:500.”
These errors have now been corrected in the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Müller-Deile, J., Sarau, G., Kotb, A.M. et al. Author Correction: Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis. Sci Rep 11, 10693 (2021). https://doi.org/10.1038/s41598-021-89610-9
Published:
DOI: https://doi.org/10.1038/s41598-021-89610-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.